Annual EBIT
-$80.89 M
-$16.90 M-26.40%
December 31, 2023
Summary
- As of February 8, 2025, HOOK annual earnings before interest & taxes is -$80.89 million, with the most recent change of -$16.90 million (-26.40%) on December 31, 2023.
- During the last 3 years, HOOK annual EBIT has fallen by -$37.60 million (-86.84%).
- HOOK annual EBIT is now -567.84% below its all-time high of -$12.11 million, reached on December 31, 2017.
Performance
HOOK EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$13.84 M
+$5.25 M+27.52%
September 30, 2024
Summary
- As of February 8, 2025, HOOK quarterly earnings before interest & taxes is -$13.84 million, with the most recent change of +$5.25 million (+27.52%) on September 30, 2024.
- Over the past year, HOOK quarterly EBIT has increased by +$5.18 million (+27.22%).
- HOOK quarterly EBIT is now -196.22% below its all-time high of $14.38 million, reached on March 31, 2024.
Performance
HOOK Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$43.16 M
+$5.18 M+10.71%
September 30, 2024
Summary
- As of February 8, 2025, HOOK TTM earnings before interest & taxes is -$43.16 million, with the most recent change of +$5.18 million (+10.71%) on September 30, 2024.
- Over the past year, HOOK TTM EBIT has increased by +$25.11 million (+36.78%).
- HOOK TTM EBIT is now -890.73% below its all-time high of -$4.36 million, reached on March 31, 2018.
Performance
HOOK TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
HOOK EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -26.4% | +27.2% | +36.8% |
3 y3 years | -86.8% | +27.2% | +36.8% |
5 y5 years | -424.1% | -24.1% | +36.8% |
HOOK EBIT Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -26.4% | at low | -196.2% | +43.8% | at high | +46.6% |
5 y | 5-year | -91.9% | at low | -196.2% | +43.8% | -10.9% | +46.6% |
alltime | all time | -567.8% | at low | -196.2% | +43.8% | -890.7% | +46.6% |
HOOKIPA Pharma EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$13.84 M(-27.5%) | -$43.16 M(-10.7%) |
Jun 2024 | - | -$19.09 M(-232.7%) | -$48.33 M(+2.5%) |
Mar 2024 | - | $14.38 M(-158.5%) | -$47.16 M(-41.7%) |
Dec 2023 | -$80.89 M(+26.4%) | -$24.61 M(+29.4%) | -$80.89 M(+18.5%) |
Sep 2023 | - | -$19.02 M(+6.1%) | -$68.26 M(+1.2%) |
Jun 2023 | - | -$17.92 M(-7.4%) | -$67.42 M(+2.7%) |
Mar 2023 | - | -$19.35 M(+61.6%) | -$65.63 M(+2.5%) |
Dec 2022 | -$64.00 M(-14.4%) | -$11.97 M(-34.1%) | -$64.00 M(-12.4%) |
Sep 2022 | - | -$18.18 M(+12.7%) | -$73.03 M(-2.2%) |
Jun 2022 | - | -$16.12 M(-9.0%) | -$74.66 M(-1.1%) |
Mar 2022 | - | -$17.73 M(-15.6%) | -$75.47 M(+0.9%) |
Dec 2021 | -$74.77 M | -$21.01 M(+6.1%) | -$74.77 M(+13.2%) |
Sep 2021 | - | -$19.80 M(+16.9%) | -$66.03 M(+10.8%) |
Jun 2021 | - | -$16.93 M(-0.5%) | -$59.62 M(+20.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2021 | - | -$17.02 M(+38.6%) | -$49.62 M(+14.6%) |
Dec 2020 | -$43.30 M(+2.7%) | -$12.28 M(-8.4%) | -$43.30 M(+5.2%) |
Sep 2020 | - | -$13.39 M(+93.4%) | -$41.15 M(+5.8%) |
Jun 2020 | - | -$6.93 M(-35.3%) | -$38.90 M(-11.1%) |
Mar 2020 | - | -$10.70 M(+5.7%) | -$43.74 M(+3.8%) |
Dec 2019 | -$42.16 M(+173.1%) | -$10.13 M(-9.2%) | -$42.16 M(+25.0%) |
Sep 2019 | - | -$11.15 M(-5.3%) | -$33.73 M(+28.1%) |
Jun 2019 | - | -$11.77 M(+29.1%) | -$26.34 M(+30.4%) |
Mar 2019 | - | -$9.12 M(+437.8%) | -$20.20 M(+30.8%) |
Dec 2018 | -$15.44 M(+27.4%) | -$1.70 M(-54.9%) | -$15.44 M(+12.3%) |
Sep 2018 | - | -$3.76 M(-33.2%) | -$13.74 M(+37.6%) |
Jun 2018 | - | -$5.63 M(+29.2%) | -$9.98 M(+129.2%) |
Mar 2018 | - | -$4.36 M | -$4.36 M |
Dec 2017 | -$12.11 M | - | - |
FAQ
- What is HOOKIPA Pharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for HOOKIPA Pharma?
- What is HOOKIPA Pharma annual EBIT year-on-year change?
- What is HOOKIPA Pharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for HOOKIPA Pharma?
- What is HOOKIPA Pharma quarterly EBIT year-on-year change?
- What is HOOKIPA Pharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for HOOKIPA Pharma?
- What is HOOKIPA Pharma TTM EBIT year-on-year change?
What is HOOKIPA Pharma annual earnings before interest & taxes?
The current annual EBIT of HOOK is -$80.89 M
What is the all time high annual EBIT for HOOKIPA Pharma?
HOOKIPA Pharma all-time high annual earnings before interest & taxes is -$12.11 M
What is HOOKIPA Pharma annual EBIT year-on-year change?
Over the past year, HOOK annual earnings before interest & taxes has changed by -$16.90 M (-26.40%)
What is HOOKIPA Pharma quarterly earnings before interest & taxes?
The current quarterly EBIT of HOOK is -$13.84 M
What is the all time high quarterly EBIT for HOOKIPA Pharma?
HOOKIPA Pharma all-time high quarterly earnings before interest & taxes is $14.38 M
What is HOOKIPA Pharma quarterly EBIT year-on-year change?
Over the past year, HOOK quarterly earnings before interest & taxes has changed by +$5.18 M (+27.22%)
What is HOOKIPA Pharma TTM earnings before interest & taxes?
The current TTM EBIT of HOOK is -$43.16 M
What is the all time high TTM EBIT for HOOKIPA Pharma?
HOOKIPA Pharma all-time high TTM earnings before interest & taxes is -$4.36 M
What is HOOKIPA Pharma TTM EBIT year-on-year change?
Over the past year, HOOK TTM earnings before interest & taxes has changed by +$25.11 M (+36.78%)